Literature DB >> 29291449

Health risk assessment of reclaimed wastewater: A case study of a conventional water reclamation plant in Nanjing, China.

Yongfeng Deng1, Melvin Bonilla2, Hongqiang Ren1, Yan Zhang3.   

Abstract

Contaminated reclaimed wastewater has the potential to induce adverse effects on the health of wastewater workers and residents. However, few studies have focused on these health risks. In this study, we assessed the health risk of samples collected from different treatment processing units used in a typical water reclamation plant in Nanjing, China. Chemical analysis revealed that 40 semi-volatile organic compounds (SVOCs) and 6 N-nitrosamines (NAs) persisted after wastewater treatment. A health risk assessment revealed that the SVOCs in effluents pose negligible non-carcinogenic risk to wastewater workers and local residents as both the hazard quotient (HQ) and hazard index (HI) were all below 1.00. However, polycyclic aromatic hydrocarbons (PAHs), phthalate esters (PAEs) and NAs may present a carcinogenic risk, since their risk index via dermal exposure exceeded the safety limit (1.00×106), indicating that conventional treatment processes cannot effectively reduce the health risk in reclaimed wastewater. These results strongly suggest the need for the introduction of advanced treatment technologies capable of effectively removing SVOCs and NAs in water reclamation plants.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Health risk assessment; Monte Carlo simulation; N-nitrosamines; Reclaimed wastewater; Semi-volatile organic compounds

Mesh:

Substances:

Year:  2017        PMID: 29291449     DOI: 10.1016/j.envint.2017.12.034

Source DB:  PubMed          Journal:  Environ Int        ISSN: 0160-4120            Impact factor:   9.621


  1 in total

1.  SUSTAINABILITY INDICATORS FOR END-OF-LIFE CHEMICAL RELEASES AND POTENTIAL EXPOSURE.

Authors:  Jose D Hernandez-Betancur; Gerardo J Ruiz-Mercado
Journal:  Curr Opin Chem Eng       Date:  2019-12-01       Impact factor: 5.163

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.